Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide

28 August 2022 (08:15 - 09:00)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Madoka Sano

Kobe City Medical Center General Hospital, Kobe (Japan)

5 More presentations in this session

Presentation thumbnail

Prognostic implications of cardiac 82-rubidium positron emission tomography in angina patients with no perfusion defects

Ms M. Rauf (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Acute effects of COVID-19 vaccination on inflammatory, macrovasular and microvascular biomarkers

Doctor D. Terentes-Printzios (Athens, GR)

Abstract Slides

Presentation thumbnail

High sensitivity troponin I and newly/recently diagnosed coronavirus-19 disease patients presenting to the emergency department: values above and below the 99th percentile predict 28 day mortality

Professor R. Nowak (Detroit, US)

Abstract Slides

Presentation thumbnail

Classic and genetic cardiovascular risk burden and case-fatality from SARS-CoV-2 virus infection. The CARGENCORS study.

Ms A. Camps-Vilaro (Barcelona, ES)

Abstract Slides

Presentation thumbnail

Does the quality index of adherence to the evidence-based guidelines predict mortality in patients with myocardial infarction?

Mr T. Gudmundsson (Gothenburg, SE)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular risk assessment & COVID

The Event

Event poster

ESC Congress 2022

28 August 2022 08:15 CET

You may be interested in

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources